A detailed history of Los Angeles Capital Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 172,440 shares of LEGN stock, worth $6.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
172,440
Holding current value
$6.1 Million
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$32.49 - $50.28 $5.6 Million - $8.67 Million
172,440 New
172,440 $5.61 Million
Q4 2022

Feb 06, 2023

SELL
$38.8 - $55.46 $106,156 - $151,738
-2,736 Reduced 30.11%
6,351 $317,000
Q1 2022

May 06, 2022

BUY
$31.02 - $48.18 $281,878 - $437,811
9,087 New
9,087 $330,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.92B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.